“We hope to have final FDA approvals for the study in the next couple of weeks and begin treating long haulers with the drug in March,” Gaylis said.”

So it appears the LH trial will likely start in early March after the FDA approves the protocol, which is in-line with OTC’s DD a couple of weeks ago and Dr. Gaylis’ comments in a video posted last week. It seems Dr. Gaylis’ site will enroll quickly and I’m assuming the other sites will enroll with similar speed.